SEC Form 4 · accession 0001562180-18-004049
Syndax Pharmaceuticals Inc · SNDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Meury
Director
Period of report
Sep 25, 2018
Accepted (ET)
Sep 27, 2018 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395937
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.11 | Sep 25, 2018 | A | 35,000 | A | — | Sep 25, 2028 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F11/36th of the shares subject to the option shall vest monthly over a three-year period.